DAHANCA19: Loco-regional control
Eriksen, ICHNO 2015
control 75%
zalutumumab 68%
HR: 1.16 [95% CI: 0.84-1.60]
Pts. at risk Events
zalutumumab.
301
78
control
307
68
total
608
146